Form 8-K - Current report:
SEC Accession No. 0001193125-23-227670
Filing Date
2023-09-01
Accepted
2023-09-01 16:21:56
Documents
14
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d534283d8k.htm   iXBRL 8-K 29350
2 EX-10.1 d534283dex101.htm EX-10.1 53139
  Complete submission text file 0001193125-23-227670.txt   256082

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20230731.xsd EX-101.SCH 3817
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20230731_def.xml EX-101.DEF 14272
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20230731_lab.xml EX-101.LAB 23434
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20230731_pre.xml EX-101.PRE 15121
8 EXTRACTED XBRL INSTANCE DOCUMENT d534283d8k_htm.xml XML 5827
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 231232844
SIC: 2833 Medicinal Chemicals & Botanical Products